REQUEST A DEMO
Total
USD $0.00
Search more companies

Mylan Pharmaceuticals S.R.O. (Czech Republic)

Main Activities: Advertising Agencies
Full name: Mylan Pharmaceuticals S.R.O. Profile Updated: September 25, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Mylan Pharmaceuticals S.R.O. is a company in Czech Republic, with a head office in Prague. The company operates in the Advertising Agencies sector. The enterprise was incorporated on April 30, 2008. 6 - 9 (2024) employees currently work for Mylan Pharmaceuticals S.R.O.. From the latest financial highlights, Mylan Pharmaceuticals S.R.O. reported a net sales revenue drop of 97.58% in 2022. Its’ total assets recorded a negative growth of 10.56%. In 2022, Mylan Pharmaceuticals S.R.O.’s net profit margin increased by 104.41%.

Headquarters
Evropska 2590/33
Prague; The City of Prague; Postal Code: 16000

Contact Details: Purchase the Mylan Pharmaceuticals S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Mylan Pharmaceuticals S.R.O. report to view the information.
Registered Capital:
Purchase the Mylan Pharmaceuticals S.R.O. report to view the information.
Financial Auditors:
Purchase the Mylan Pharmaceuticals S.R.O. report to view the information.
Incorporation Date:
April 30, 2008
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
99.38%
Purchase this report to view the information.
0.62%
Company Performance
Financial values in the chart are available after Mylan Pharmaceuticals S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
-97.58%
Total Operating Revenue
-97.57%
Operating Profit
-97.59%
EBITDA
-97.59%
Net Profit/Loss for the Period
-34.4%
Total Assets
-10.56%
Total Equity
4.27%
Operating Profit Margin
-0.01%
Net Profit Margin
104.41%
Return on Equity (ROE)
-2.39%
Quick Ratio
188.65%
Cash Ratio
27.54%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?